Next Article in Journal
PEGylated Terpesome-Loaded 3D-Printed Aripiprazole Ocuserts for the Treatment of Ocular Candidiasis
Previous Article in Journal
Synthesis and Characterization of Triphenyl Phosphonium-Modified Triterpenoids with Never Reported Antibacterial Effects Against Clinically Relevant Gram-Positive Superbugs
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Pharmaceutics
Volume 17
Issue 12
10.3390/pharmaceutics17121615
pharmaceutics-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles
Correction to Pharmaceutics 2025, 17(5), 614.
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Correction

Correction: Chen et al. Neutrophil-Camouflaged Stealth Liposomes for Photothermal-Induced Tumor Immunotherapy Through Intratumoral Bacterial Activation. Pharmaceutics 2025, 17, 614

by
Xinxin Chen
1,
Jiang Sun
2,
Tingxian Ye
1 and
Fanzhu Li
1,*
1
School of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Hangzhou 310053, China
2
Jinhua Academy of Zhejiang Chinese Medical University, Jinhua 321015, China
*
Author to whom correspondence should be addressed.
Pharmaceutics 2025, 17(12), 1615; https://doi.org/10.3390/pharmaceutics17121615
Submission received: 28 November 2025 / Accepted: 3 December 2025 / Published: 16 December 2025
Browse Figures
Versions Notes
Error in Figure
In the original publication [1], there was a mistake in Figures 3 and 6 as published. The authors would like to make the following updates to the published article [1] to ensure the clarity and completeness of the presented data. An error occurred during the editing of Figure 3, where the Calcein images of the PBS group and the PD/GA-LPS-NE group were incorrectly arranged. Upon reviewing the raw data, we confirmed that we completely merged the images for the PD/GA-LPS-NE group. In Figure 6, the photographs for Group 6 and Group 7 were mistakenly imported during the processing of images captured by mobile phones. We also noted that the Ki67 images of Group 4 and Group 5, as well as the TUNEL images of Group 2 and Group 5, were accidentally duplicated due to missing links in the original images in the Adobe Illustrator workflow. Furthermore, immunofluorescence images from the PBS group were used as substitutes to address the erroneous application of TUNEL images in Group 1, resulting from the broken file links during the migration of the original folder. The corrected Figure 3 and Figure 6 are presented below. The authors state that the scientific conclusions are unaffected. This correction was approved by the Academic Editor. The original publication has also been updated.

Reference

  1. Chen, X.; Sun, J.; Ye, T.; Li, F. Neutrophil-Camouflaged Stealth Liposomes for Photothermal-Induced Tumor Immunotherapy Through Intratumoral Bacterial Activation. Pharmaceutics 2025, 17, 614. [Google Scholar] [CrossRef] [PubMed]
Pharmaceutics 17 01615 g003
Figure 3. In vitro anticancer effects of PD/GA-LPs against 4T1 cells. (A) Cell viability of 4T1 cells incubated with various formulations for 24 h (n = 4). (B) Cell viability of 4T1 cells after PD/GA-LPs-NEs treatment for 24 h with or without laser irradiation (n = 4). (C) Live-dead staining of 4T1 treated with PBS and different formulations for 4 h (Scale bar: 100 µm). (D) Apoptosis analysis via an Annexin V-FITC/PI assay of 4T1 cells incubated with PBS and different formulations for 4 h (n = 3). (E) CLSM images of the expression of the HSP90 protein in 4T1 cells after various treatments (Scale bar: 20 µm). (F) CLSM images of the expression of the HSP70 protein in 4T1 cells after various treatments (Scale bar: 20 µm). (* p < 0.05, ** p < 0.01, *** p < 0.001).
Figure 3. In vitro anticancer effects of PD/GA-LPs against 4T1 cells. (A) Cell viability of 4T1 cells incubated with various formulations for 24 h (n = 4). (B) Cell viability of 4T1 cells after PD/GA-LPs-NEs treatment for 24 h with or without laser irradiation (n = 4). (C) Live-dead staining of 4T1 treated with PBS and different formulations for 4 h (Scale bar: 100 µm). (D) Apoptosis analysis via an Annexin V-FITC/PI assay of 4T1 cells incubated with PBS and different formulations for 4 h (n = 3). (E) CLSM images of the expression of the HSP90 protein in 4T1 cells after various treatments (Scale bar: 20 µm). (F) CLSM images of the expression of the HSP70 protein in 4T1 cells after various treatments (Scale bar: 20 µm). (* p < 0.05, ** p < 0.01, *** p < 0.001).
Pharmaceutics 17 01615 g003
Pharmaceutics 17 01615 g006
Figure 6. In vivo antitumor evaluation. (A) Schematic illustration of the procedure of administration in vivo. (B) Images of tumors harvested from 4T1-bearing mice on day 15 after various treatments. (C) The growth profiles of 4T1 tumors in mice that received different treatments. (D) Survival curves of 4T1 tumor-bearing mice after various treatments. (E) Colony plate images of tumors harvested from mice receiving different treatments on their 15th day. (F) H&E staining, Ki-67, and TUNEL immunohistochemical images of the tumor harvested from 4T1-bearing mice after different treatments (Scale bar: 100 µm) (*** p < 0.001).
Figure 6. In vivo antitumor evaluation. (A) Schematic illustration of the procedure of administration in vivo. (B) Images of tumors harvested from 4T1-bearing mice on day 15 after various treatments. (C) The growth profiles of 4T1 tumors in mice that received different treatments. (D) Survival curves of 4T1 tumor-bearing mice after various treatments. (E) Colony plate images of tumors harvested from mice receiving different treatments on their 15th day. (F) H&E staining, Ki-67, and TUNEL immunohistochemical images of the tumor harvested from 4T1-bearing mice after different treatments (Scale bar: 100 µm) (*** p < 0.001).
Pharmaceutics 17 01615 g006
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Chen, X.; Sun, J.; Ye, T.; Li, F. Correction: Chen et al. Neutrophil-Camouflaged Stealth Liposomes for Photothermal-Induced Tumor Immunotherapy Through Intratumoral Bacterial Activation. Pharmaceutics 2025, 17, 614. Pharmaceutics 2025, 17, 1615. https://doi.org/10.3390/pharmaceutics17121615

AMA Style

Chen X, Sun J, Ye T, Li F. Correction: Chen et al. Neutrophil-Camouflaged Stealth Liposomes for Photothermal-Induced Tumor Immunotherapy Through Intratumoral Bacterial Activation. Pharmaceutics 2025, 17, 614. Pharmaceutics. 2025; 17(12):1615. https://doi.org/10.3390/pharmaceutics17121615

Chicago/Turabian Style

Chen, Xinxin, Jiang Sun, Tingxian Ye, and Fanzhu Li. 2025. "Correction: Chen et al. Neutrophil-Camouflaged Stealth Liposomes for Photothermal-Induced Tumor Immunotherapy Through Intratumoral Bacterial Activation. Pharmaceutics 2025, 17, 614" Pharmaceutics 17, no. 12: 1615. https://doi.org/10.3390/pharmaceutics17121615

APA Style

Chen, X., Sun, J., Ye, T., & Li, F. (2025). Correction: Chen et al. Neutrophil-Camouflaged Stealth Liposomes for Photothermal-Induced Tumor Immunotherapy Through Intratumoral Bacterial Activation. Pharmaceutics 2025, 17, 614. Pharmaceutics, 17(12), 1615. https://doi.org/10.3390/pharmaceutics17121615

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Article metric data becomes available approximately 24 hours after publication online.
Back to TopTop